Page last updated: 2024-11-04

sulfasalazine and Autoimmune Demyelinating Disease, Peripheral

sulfasalazine has been researched along with Autoimmune Demyelinating Disease, Peripheral in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"The neurological manifestations of Crohn's disease are rare, dominated by multiple mononeuropathies and the abnormalities of the white matter."1.34[Crohn's disease presenting with recurrent acute polyradiculoneuropathy]. ( El Moutawakil, B; Gam, I; Rafai, MA; Rhimou, A; Slassi, I; Tahiri, JM, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El Moutawakil, B1
Rafai, MA1
Gam, I1
Tahiri, JM1
Rhimou, A1
Slassi, I1

Other Studies

1 other study available for sulfasalazine and Autoimmune Demyelinating Disease, Peripheral

ArticleYear
[Crohn's disease presenting with recurrent acute polyradiculoneuropathy].
    Revue neurologique, 2007, Volume: 163, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Budesonide; Combined Modality Therapy; Crohn Disease; Diarrhea; Dru

2007